Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

Our premium News+ ad-free experience – only $10 more every 4 weeks!

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

Dr. Anastasia Khvorova for her pioneering work in the field of RNA-based therapies. At 2.5 million euros, the prize is one of the most prestigious and generously endowed of any medical research prize ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress.

The interaction between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has emerged as a key area of interest in ...

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, announced today that it has entered into a strategic global research collaboration and licensing ...